Announcement • Jun 30
Jiang Su Yida Chemical Co.,Ltd to Report First Half, 2026 Results on Aug 22, 2026 Jiang Su Yida Chemical Co.,Ltd announced that they will report first half, 2026 results on Aug 22, 2026 Buy Or Sell Opportunity • May 14
Now 31% overvalued after recent price rise Over the last 90 days, the stock has risen 56% to CN¥24.47. The fair value is estimated to be CN¥18.73, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Announcement • Apr 28
Jiang Su Yida Chemical Co.,Ltd announced that it expects to receive CNY 300 million in funding Jiang Su Yida Chemical Co.,Ltd announced a private placement of A shares not more than 30% of total share capital at a price of not less than 80% of the average price in the 20 trading days before the pricing reference date for gross proceeds of not more than CNY 300,000,000 on April 27, 2026. The transaction will include participation from not more than 35 investors. The shares cannot be transferred within 6 months from the issuance closing date. The transaction has been approved at the 10th meeting of the 5th directorate of the company. The transaction is subject to the approval of the company’s annual shareholders meeting of 2025. Reported Earnings • Apr 28
First quarter 2026 earnings released: EPS: CN¥0.026 (vs CN¥0.22 loss in 1Q 2025) First quarter 2026 results: EPS: CN¥0.026 (up from CN¥0.22 loss in 1Q 2025). Revenue: CN¥547.9m (up 65% from 1Q 2025). Net income: CN¥4.31m (up CN¥40.5m from 1Q 2025). Profit margin: 0.8% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Announcement • Apr 28
Jiang Su Yida Chemical Co.,Ltd, Annual General Meeting, May 20, 2026 Jiang Su Yida Chemical Co.,Ltd, Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Jiangyin, Jiangsu China New Risk • Apr 23
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 41% per year over the past 5 years. Announcement • Mar 31
Jiang Su Yida Chemical Co.,Ltd to Report Q1, 2026 Results on Apr 28, 2026 Jiang Su Yida Chemical Co.,Ltd announced that they will report Q1, 2026 results on Apr 28, 2026 New Risk • Feb 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Earnings have declined by 41% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change). Announcement • Dec 31
Jiang Su Yida Chemical Co.,Ltd to Report Fiscal Year 2025 Results on Apr 28, 2026 Jiang Su Yida Chemical Co.,Ltd announced that they will report fiscal year 2025 results on Apr 28, 2026 Reported Earnings • Oct 25
Third quarter 2025 earnings released: CN¥0.16 loss per share (vs CN¥0.011 profit in 3Q 2024) Third quarter 2025 results: CN¥0.16 loss per share (down from CN¥0.011 profit in 3Q 2024). Revenue: CN¥420.0m (down 8.5% from 3Q 2024). Net loss: CN¥26.8m (down CN¥28.7m from profit in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. Announcement • Sep 30
Jiang Su Yida Chemical Co.,Ltd to Report Q3, 2025 Results on Oct 25, 2025 Jiang Su Yida Chemical Co.,Ltd announced that they will report Q3, 2025 results on Oct 25, 2025 Announcement • Jul 02
Jiang Su Yida Chemical Co.,Ltd to Report First Half, 2025 Results on Aug 27, 2025 Jiang Su Yida Chemical Co.,Ltd announced that they will report first half, 2025 results on Aug 27, 2025 Declared Dividend • Jun 12
Dividend reduced to CN¥0.03 Dividend of CN¥0.03 is 70% lower than last year. Ex-date: 17th June 2025 Payment date: 17th June 2025 Dividend yield will be 0.2%, which is lower than the industry average of 2.6%. Announcement • Apr 22
Jiang Su Yida Chemical Co.,Ltd Approves Cash Dividend for the Year 2024 Jiang Su Yida Chemical Co.,Ltd held its Annual General Meeting of 2024 held on 18 April 2025, approved cash dividend/10 shares (tax included): CNY 0.30000000 for the year 2024. Announcement • Mar 31
Jiang Su Yida Chemical Co.,Ltd to Report Q1, 2025 Results on Apr 24, 2025 Jiang Su Yida Chemical Co.,Ltd announced that they will report Q1, 2025 results on Apr 24, 2025 New Risk • Mar 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Earnings have declined by 5.1% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.0% average weekly change). Large one-off items impacting financial results. Reported Earnings • Mar 28
Full year 2024 earnings released: EPS: CN¥0.058 (vs CN¥0.24 loss in FY 2023) Full year 2024 results: EPS: CN¥0.058 (up from CN¥0.24 loss in FY 2023). Revenue: CN¥1.77b (down 2.5% from FY 2023). Net income: CN¥9.53m (up CN¥44.8m from FY 2023). Profit margin: 0.5% (up from net loss in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance. Announcement • Mar 28
Jiang Su Yida Chemical Co.,Ltd, Annual General Meeting, Apr 18, 2025 Jiang Su Yida Chemical Co.,Ltd, Annual General Meeting, Apr 18, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Jiangyin, Jiangsu China Announcement • Dec 31
Jiang Su Yida Chemical Co.,Ltd to Report Fiscal Year 2024 Results on Mar 28, 2025 Jiang Su Yida Chemical Co.,Ltd announced that they will report fiscal year 2024 results on Mar 28, 2025 Board Change • Nov 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 2 highly experienced directors. Independent Director Qiang Chen was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Oct 25
Third quarter 2024 earnings released: EPS: CN¥0.011 (vs CN¥0.01 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.011 (up from CN¥0.01 in 3Q 2023). Revenue: CN¥458.9m (down 5.3% from 3Q 2023). Net income: CN¥1.81m (up 10% from 3Q 2023). Profit margin: 0.4% (up from 0.3% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥12.72, the stock trades at a trailing P/E ratio of 74.6x. Average trailing P/E is 31x in the Chemicals industry in China. Total loss to shareholders of 55% over the past three years. Announcement • Sep 30
Jiang Su Yida Chemical Co.,Ltd to Report Q3, 2024 Results on Oct 23, 2024 Jiang Su Yida Chemical Co.,Ltd announced that they will report Q3, 2024 results on Oct 23, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to CN¥13.60, the stock trades at a trailing P/E ratio of 79.7x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 48% over the past three years. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥10.75, the stock trades at a trailing P/E ratio of 63x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 58% over the past three years. Reported Earnings • Jul 25
Second quarter 2024 earnings released: EPS: CN¥0.047 (vs CN¥0.29 loss in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.047 (up from CN¥0.29 loss in 2Q 2023). Revenue: CN¥470.7m (down 7.2% from 2Q 2023). Net income: CN¥7.69m (up CN¥33.2m from 2Q 2023). Profit margin: 1.6% (up from net loss in 2Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 46 percentage points per year, which is a significant difference in performance. Announcement • Jun 29
Jiang Su Yida Chemical Co.,Ltd to Report First Half, 2024 Results on Jul 25, 2024 Jiang Su Yida Chemical Co.,Ltd announced that they will report first half, 2024 results on Jul 25, 2024 Announcement • Jun 25
Jiang Su Yida Chemical Co.,Ltd Announces Final Cash Dividend on A Shares for 2023, Payable on 28 June 2024 Jiang Su Yida Chemical Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 1.00000000. Record date: 27 June 2024. Ex-date: 28 June 2024. Payment date: 28 June 2024. Announcement • Apr 21
Jiang Su Yida Chemical Co.,Ltd, Annual General Meeting, May 13, 2024 Jiang Su Yida Chemical Co.,Ltd, Annual General Meeting, May 13, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Jiangyin, Jiangsu China Reported Earnings • Apr 20
Full year 2023 earnings released: CN¥0.24 loss per share (vs CN¥0.68 profit in FY 2022) Full year 2023 results: CN¥0.24 loss per share (down from CN¥0.68 profit in FY 2022). Revenue: CN¥1.81b (up 17% from FY 2022). Net loss: CN¥35.3m (down 132% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 19% per year. Announcement • Mar 30
Jiang Su Yida Chemical Co.,Ltd to Report Q1, 2024 Results on Apr 27, 2024 Jiang Su Yida Chemical Co.,Ltd announced that they will report Q1, 2024 results on Apr 27, 2024 New Risk • Mar 27
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (1.1% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (12% average weekly change). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). New Risk • Feb 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (3.8% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (8.4% average weekly change). Announcement • Dec 29
Jiang Su Yida Chemical Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024 Jiang Su Yida Chemical Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024 Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.30 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.01 (down from CN¥0.30 in 3Q 2022). Revenue: CN¥484.7m (up 16% from 3Q 2022). Net income: CN¥1.64m (down 96% from 3Q 2022). Profit margin: 0.3% (down from 11% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 6% per year. New Risk • Oct 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (1.1% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (7.9% average weekly change). Reported Earnings • Aug 24
Second quarter 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.22 profit in 2Q 2022) Second quarter 2023 results: CN¥0.16 loss per share (down from CN¥0.22 profit in 2Q 2022). Revenue: CN¥507.5m (up 32% from 2Q 2022). Net loss: CN¥25.5m (down 173% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 29
First quarter 2023 earnings released: CN¥0.29 loss per share (vs CN¥0.26 profit in 1Q 2022) First quarter 2023 results: CN¥0.29 loss per share (down from CN¥0.26 profit in 1Q 2022). Revenue: CN¥371.7m (down 1.3% from 1Q 2022). Net loss: CN¥25.3m (down 161% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Reported Earnings • Feb 21
Full year 2022 earnings released: EPS: CN¥1.28 (vs CN¥1.55 in FY 2021) Full year 2022 results: EPS: CN¥1.28 (down from CN¥1.55 in FY 2021). Revenue: CN¥1.55b (up 7.2% from FY 2021). Net income: CN¥109.6m (down 17% from FY 2021). Profit margin: 7.0% (down from 9.1% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 27
Third quarter 2022 earnings released: EPS: CN¥0.56 (vs CN¥0.37 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.56 (up from CN¥0.37 in 3Q 2021). Revenue: CN¥417.6m (up 11% from 3Q 2021). Net income: CN¥46.2m (up 45% from 3Q 2021). Profit margin: 11% (up from 8.4% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 05
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥54.04, the stock trades at a trailing P/E ratio of 31.5x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 176% over the past three years. Valuation Update With 7 Day Price Move • Aug 09
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥36.90, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 96% over the past three years. Reported Earnings • Aug 01
Second quarter 2022 earnings released: EPS: CN¥0.42 (vs CN¥0.50 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.42 (down from CN¥0.50 in 2Q 2021). Revenue: CN¥384.0m (down 1.2% from 2Q 2021). Net income: CN¥34.9m (down 18% from 2Q 2021). Profit margin: 9.1% (down from 11% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Announcement • May 21
Jiangsu Yida Chemical Co., Ltd. Announces Final Dividend on A Share for the Year 2021, Payable on 27 May 2022 Jiangsu Yida Chemical Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 1.00000000 on A shares for the year 2021. Record date is 26 May 2022. Ex-date is 27 May 2022. Payment date is 27 May 2022. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥0.50 (vs CN¥0.22 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.50 (up from CN¥0.22 in 1Q 2021). Revenue: CN¥376.5m (up 26% from 1Q 2021). Net income: CN¥41.5m (up 125% from 1Q 2021). Profit margin: 11% (up from 6.2% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥39.05, the stock trades at a trailing P/E ratio of 25.4x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 81% over the past three years. Reported Earnings • Mar 15
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: CN¥1.55 (up from CN¥0.05 loss in FY 2020). Revenue: CN¥1.45b (up 44% from FY 2020). Net income: CN¥131.8m (up CN¥135.7m from FY 2020). Profit margin: 9.1% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Nov 22
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥57.17, the stock trades at a trailing P/E ratio of 52.2x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 172% over the past three years. Board Change • Nov 01
High number of new directors Independent Director Qiang Chen was the last director to join the board, commencing their role in 2021. Reported Earnings • Oct 23
Third quarter 2021 earnings released: EPS CN¥0.37 (vs CN¥0.037 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥377.3m (up 28% from 3Q 2020). Net income: CN¥31.8m (up CN¥28.9m from 3Q 2020). Profit margin: 8.4% (up from 1.0% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 21
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥58.82, the stock trades at a trailing P/E ratio of 78.2x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 175% over the past three years. Board Change • Oct 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. Non-Independent Director Jingzhen Zhao was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥51.71, the stock trades at a trailing P/E ratio of 68.8x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 119% over the past three years. Valuation Update With 7 Day Price Move • Aug 24
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥63.05, the stock trades at a trailing P/E ratio of 78.2x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 137% over the past three years. Reported Earnings • Jul 31
Second quarter 2021 earnings released: EPS CN¥0.50 (vs CN¥0.016 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥388.6m (up 51% from 2Q 2020). Net income: CN¥42.6m (up CN¥43.8m from 2Q 2020). Profit margin: 11% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings. Reported Earnings • Apr 26
Full year 2020 earnings released: CN¥0.05 loss per share (vs CN¥0.082 profit in FY 2019) The company reported a soft full year result with weaker earnings and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: CN¥1.00b (up 5.2% from FY 2019). Net loss: CN¥3.88m (down 159% from profit in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 109 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Jan 15
New 90-day high: CN¥39.07 The company is up 10.0% from its price of CN¥35.65 on 16 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Dec 28
New 90-day low: CN¥29.89 The company is down 12% from its price of CN¥34.05 on 29 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. Is New 90 Day High Low • Nov 19
New 90-day high: CN¥36.97 The company is up 38% from its price of CN¥26.71 on 21 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total losses of CN¥7.91m, with earnings decreasing by CN¥18.9m from the prior year. Total revenue was CN¥982.7m over the last 12 months, up 3.1% from the prior year. Is New 90 Day High Low • Oct 09
New 90-day high: CN¥35.22 The company is up 34% from its price of CN¥26.36 on 10 July 2020. The Chinese market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. Announcement • Jul 18
Jiangsu Yida Chemical Co., Ltd. to Report First Half, 2020 Results on Jul 31, 2020 Jiangsu Yida Chemical Co., Ltd. announced that they will report first half, 2020 results on Jul 31, 2020